These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

117 related articles for article (PubMed ID: 336245)

  • 21. Depot-bromocriptine treatment for prolactinomas and acromegaly.
    Grossman A; Ross R; Wass JA; Besser GM
    Clin Endocrinol (Oxf); 1986 Feb; 24(2):231-8. PubMed ID: 3708874
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Acromegaly--results of long term treatment with bromocriptine.
    Besser GM; Wass JA; Thorner MO
    Acta Endocrinol Suppl (Copenh); 1978; 216():187-98. PubMed ID: 347861
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Superiority of bromocriptine over pyridoxine in the treatment of patients with acromegaly or galactorrhea.
    Blum I; Segal S; Kaufman H; Sagiv M; Shalit M; Chowers I
    Isr J Med Sci; 1980 Jan; 16(1):12-6. PubMed ID: 7188934
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Medical management of acromegaly with bromocriptine. Effects of continuous treatment for over three years.
    Besser GM; Wass JA
    Med J Aust; 1978 Nov; 2(3 Suppl):31-3. PubMed ID: 745579
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Bioactive GH-like immunoglobulins G in active acromegaly: response to long-term treatment with bromocriptine.
    Campino C; Szecowka J; Lopez JM; Seron-Ferre M
    Clin Endocrinol (Oxf); 1995 Jul; 43(1):111-6. PubMed ID: 7641402
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The influence of bromocriptine on serum levels of growth hormone and other pituitary hormones and its metabolic effects in active acromegaly.
    Roelfsema F; Goslings BM; Frölich M; Moolenaar AJ; Seters AP; Van Slooten H
    Clin Endocrinol (Oxf); 1979; 11(2):235-44. PubMed ID: 114344
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Changes of molecular forms of growth hormone in bromocriptine treated acromegaly in relation to changes of somatomedin-C and clinical response.
    Nortier JW; Croughs RJ; Donker GH; Thijssen JH; Schwarz F
    Acta Endocrinol (Copenh); 1985 Feb; 108(2):145-50. PubMed ID: 4038567
    [TBL] [Abstract][Full Text] [Related]  

  • 28. A randomized study of SMS 201-995 versus bromocriptine treatment in acromegaly: clinical and biochemical effects.
    Halse J; Harris AG; Kvistborg A; Kjartansson O; Hanssen E; Smiseth O; Djøsland O; Hass G; Jervell J
    J Clin Endocrinol Metab; 1990 May; 70(5):1254-61. PubMed ID: 2186055
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Treatment with octreotide and bromocriptine in patients with acromegaly: an open pharmacodynamic interaction study.
    Fredstorp L; Kutz K; Werner S
    Clin Endocrinol (Oxf); 1994 Jul; 41(1):103-8. PubMed ID: 8050122
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Complete remission of acromegaly with medical treatment.
    Spark RF; Dickstein G; Pallotta J
    JAMA; 1979 Feb; 241(6):573-5. PubMed ID: 762812
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Bromocriptine treatment over 12 years in acromegaly: effect on growth hormone and prolactin secretion.
    Rau H; Althoff PH; Schmidt K; Usadel KH
    Acta Endocrinol (Copenh); 1992 Mar; 126(3):247-52. PubMed ID: 1574954
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bromocriptine therapy in acromegaly. A long-term review of 35 cases.
    Sachdev Y; Gopal K; Garg VK
    Postgrad Med J; 1981 Apr; 57(666):210-6. PubMed ID: 7027229
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Treatment of acromegaly with bromocriptine.
    Wang C; Chan V; Yeung RT
    Aust N Z J Med; 1979 Jun; 9(3):225-32. PubMed ID: 288387
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Long-term treatment of acromegaly with bromocryptine: postprandial HGH levels and response to TRH and glucose administration.
    Benker G; Zäh W; Hackenberg K; Hamburger B; Günnewig H; Reinwein D
    Horm Metab Res; 1976 Jul; 8(4):291-5. PubMed ID: 182633
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Measurement of the 24 hour integrated plasma concentration of growth hormone, in assessing the response of acromegalic patients to treatment.
    Daggett PR; Nabarro JD
    Clin Endocrinol (Oxf); 1977 Dec; 7(6):437-41. PubMed ID: 563781
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Bromoergocryptin treatment of acromegaly persisting following conventional therapy.
    Holdaway IM; Frengley PA; Scott DJ; Ibbertson HK
    Clin Endocrinol (Oxf); 1978 Jan; 8(1):45-54. PubMed ID: 627091
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Long-term treatment of acromegalic patients with repeatable parenteral depot-bromocriptine.
    Jaspers C; Haase R; Pfingsten H; Benker G; Reinwein D
    Clin Investig; 1993 Jul; 71(7):547-51. PubMed ID: 8374248
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effect of a somatostatin analogue on trophic hormone levels in acromegalic patients with elevated hGH after adenomectomy and treatment with bromocriptine.
    Szilágyi G; Irsy G; Góth M; Szabolcs I; Coy DH; Comaru-Schally AM; Schally AV
    Exp Clin Endocrinol; 1984 Oct; 84(2):190-6. PubMed ID: 6543182
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bromocriptine reduces growth hormone in acromegaly.
    Bell PM; Atkinson AB; Hadden DR; Kennedy L; Leslie H; Merrett JD; Sheridan B
    Arch Intern Med; 1986 Jun; 146(6):1145-9. PubMed ID: 3718102
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bromocriptine therapy in patients with acromegaly: effects on growth hormone, somatomedin A and prolactin.
    Werner S; Hall K; Sjöberg HE
    Acta Endocrinol Suppl (Copenh); 1978; 216():199-206. PubMed ID: 347862
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.